Lu’s team then cultured the edited cells, increasing their number, and injected them back into the patient, who has metastatic non-small-cell lung cancer. A research team at Sichuan University in China have delivered modified doses to a patient with severe lung cancer via the Clustered Regularly - Short Palindromic Repeats ( CRISPR ) – Cas9 technique as part of a clinical trial . The research team have claimed the first dosage went “ smoothly ” , but further details were not publicised . However , Naiyer Rizvi of Columbia University Medical Center in New York City doubts the trial will succeed .
A research team at Sichuan University in China have delivered modified doses to a patient with severe lung cancer via the Clustered Regularly - Short Palindromic Repeats ( CRISPR ) – Cas9 technique as part of a clinical trial . The research team have claimed the first dosage went “ smoothly ” , but further details were not publicised . However , Naiyer Rizvi of Columbia University Medical Center in New York City doubts the trial will succeed .